SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The impacts of medication shortages on patient outcomes: A scoping review
4 references·10 citing·35 second hop
The impacts of medication shortages on patient outcomes: A scoping review (2019)The impacts of medication shortages on pa…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…The introduction, methods, results, and discussion (IMRAD) structure: a fifty-year survey. (2004)The introduction, methods, re…Pharmaceutical Supply Chains and Drug Shortages (2023)Pharmaceutical Supply Chains …Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach (2023)Digitalization enhancement in…The pros and cons of reshoring to address the problems of shortages in global pharmaceutical value chains: the case of antibiotics (2022)The pros and cons of reshorin…Stock-outs of essential medicines among community health workers (CHWs) in low- and middle-income countries (LMICs): a systematic literature review of the extent, reasons, and consequences (2022)Stock-outs of essential medic…5-year inventory management of drug products using ABC-VEN analysis in the pharmacy store of a specialized public hospital in Vietnam (2022)5-year inventory management o…Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory (2021)Advancing the understanding o…Vulnerability of the medical product supply chain: the wake-up call of COVID-19 (2020)Vulnerability of the medical …New regulatory strategies to manage medicines shortages in Europe (2020)New regulatory strategies to …How to address medicines shortages: Findings from a cross-sectional study of 24 countries (2020)How to address medicines shor…A multi-attribute utility theory approach to ordering policy for perishable items (2019)A multi-attribute utility the…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)Causes of drug shortages in the legal pharmaceutical framework (2015)Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending (2017)Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018)Process integration for emerging challenges: optimal allocation of antivirals under resource constraints (2020)The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)Pharmaceutical Price Controls and Entry Strategies (2007)How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries (2017)Managing Risk To Avoid Supply-Chain Breakdown (2004)Understanding the concept of supply chain resilience (2009)Research on the phenomenon of supply chain resilience (2015)The role of healthcare supply chain management in the wake of COVID-19 pandemic: hot off the press (2021)Digital Twins on the Resilience of Supply Chain Under COVID-19 Pandemic (2022)Mitigating personal protective equipment (PPE) supply chain disruptions in pandemics – a system dynamics approach (2022)Building the Resilient Supply Chain (2004)Code Saturation Versus Meaning Saturation (2016)Modelling enablers for building agri-food supply chain resilience: insights from a comparative analysis of Argentina and France (2022)Resilience capabilities of healthcare supply chain and supportive digital technologies (2022)Knowledge management for supply chain resilience in pharmaceutical industry: evidence from the Middle East region (2023)Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study (2013)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Measuring the efficiency of decision making units (1978)Risk evaluation in failure mode and effects analysis using fuzzy weighted geometric mean (2007)A digital supply chain twin for managing the disruption risks and resilience in the era of Industry 4.0 (2020)CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (2008)Summary-of-findings tables in Cochrane reviews improved understanding and rapid retrieval of key information (2010)The history of the case report: a selective review (2014)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement63,979 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 2004The introduction, methods, results, and discussion (IMRAD) structure: a fifty-year survey.364 cited

Cited by

  • 2020Vulnerability of the medical product supply chain: the wake-up call of COVID-19116 cited
  • 2021Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory100 cited
  • 2020New regulatory strategies to manage medicines shortages in Europe80 cited
  • 2022Stock-outs of essential medicines among community health workers (CHWs) in low- and middle-income countries (LMICs): a systematic literature review of the extent, reasons, and consequences70 cited
  • 2020How to address medicines shortages: Findings from a cross-sectional study of 24 countries59 cited
  • 2023Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach48 cited
  • 20225-year inventory management of drug products using ABC-VEN analysis in the pharmacy store of a specialized public hospital in Vietnam19 cited
  • 2022The pros and cons of reshoring to address the problems of shortages in global pharmaceutical value chains: the case of antibiotics19 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2023
Pharmaceutical Supply Chains and Drug Shortages
15 cited
  • 2019A multi-attribute utility theory approach to ordering policy for perishable items14 cited